secwatch / observer
8-K/A filed December 7, 2022, 6:59 PM ET ticker IBIO CIK 0001420720
leadership confidence high sentiment neutral materiality 0.60

CEO Thomas Isett resigns effective immediately; interim office of CEO established

iBio, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Thomas F. Isett

Chief Executive Officer
IBIO · iBio, Inc.
Effective
2022-12-01
Filed
December 7, 2022, 6:59 PM ET
Mr. Thomas F. Isett, the Chief Executive Officer (the “CEO”) of iBio, Inc., (the “Company”) and a member of the Board of Directors (the “Board”), and the Company, agreed for Mr. Isett to resign as a member of the Board and relinquish his duties, rights and obligations as an officer and the CEO of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas F. Isett resigned as Chief Executive Officer at iBio, Inc..

Action
resigned
Role
Chief Executive Officer
Exact text from the filing
Mr. Thomas F. Isett, the Chief Executive Officer (the “CEO”) of iBio, Inc., (the “Company”) and a member of the Board of Directors (the “Board”), and the Company, agreed for Mr. Isett to resign as a member of the Board and relinquish his duties, rights and obligations as an officer and the CEO of the Company, effective immediately.
View on SEC.gov

iBio, Inc. filing history →

Source: SEC EDGAR
accession 0001420720-22-000091
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.